课题基金 / 基金详情

项目摘要

项目成果

BLAKE PETERSON的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 合成化学生物学核心(SCBC)成立于2016年7月,由 疾病途径分子分析(CMADP)分子探针核心(MPC)与新成立的 传染病化学生物学(CBID)药物化学核心(MCC)。的综合能力 SCBC将实现两个科布雷中心的具体目标。SCBC在第二阶段的任务是提供 附属于CMADP的初级教员,以及堪萨斯州的其他研究人员,拥有新的分子 生物系统的探测器。SCBC还将提供对这些探针进行整体体外评估的能力。 细胞生物分析,以及在斑马鱼体内,斑马鱼是一种日益重要的生物医学研究模式生物。这个 SCBC还将履行CBID关于抗感染药物发现的任务。这些项目将得到资助 通过CBID。SCBC主管负责协调两个Cobre的所有SCBC核心实验室活动 中锋。SCBC将提供分子探针的专家设计和小分子和 多肽,重点是荧光分子和其他标记分子的产生。SCBC还将提供 分子探针的生物分析,包括全细胞分析和使用斑马鱼的分析,以弥补 目前存在于培养细胞的极高分辨率成像和低分辨率的荧光成像之间 啮齿动物体内的示踪剂。新成立的SCBC将与其他由CMADP资助的核心项目协同发挥作用 包括基因组测序核心在内的设施,以识别影响体内探针功能的基因,以及 微制造和微流控核心,用于开发成像和化学分析设备。这 整合的目的是使教师能够使用化学生物学的方法来研究生物学 有问题。 SCBC为调查人员提供了接触具有合成有机经验的高素质人员的途径 化学、生物化学、显微镜和优化合成的生物特性的方法 分子。该中心有来自KU药物化学系的两名共同核心领导人。布莱克教授 彼得森将继续担任CMADP在SCBC中的领导。汤姆·普里辛扎诺教授是该项目的领导者 SCBC的CBID部分。SCBC的主任是查马尼·佩雷拉博士。具体目标将是 常委会就这项第二阶段建议所处理的事项如下:(1)继续整合拟议 Cobre疾病通路分子分析中心与现有的Cobre中心合作 传染病化学生物学一期进一步建立新的SCBC,获得规模经济, 为Cobre CMADP所属院系服务;(2)生物分子探针的设计与合成 学院研究人员的系统;(3)使学院客户能够进行细胞培养和斑马鱼的生物检测 模型;以及(4)提供管理核心活动所需的外展和行政支持,并提供 为堪萨斯州更大的生物医学研究社区提供服务。
英文摘要
PROJECT SUMMARY The Synthetic Chemical Biology Core (SCBC) was established in July 2016 from the merger of the Center for Molecular Analysis of Disease Pathways (CMADP) Molecular Probes Core (MPC) with the newly established Chemical Biology of Infectious Disease (CBID) Medicinal Chemistry Core (MCC). The synthetic capabilities of the SCBC will fulfill the specific aims of both COBRE centers. The mission for the SCBC in Phase II is to provide the junior faculty affiliated with CMADP, as well as other investigators in the state of Kansas, with novel molecular probes of biological systems. The SCBC will also offer the capability to evaluate these probes in vitro in whole- cell bioassays, and in vivo in zebrafish, an increasingly important model organism for biomedical research. The SCBC will also fulfill CBID’s missions concerning anti-infective drug discovery. These projects will be funded through the CBID. The SCBC Director is responsible for coordinating all SCBC Core lab activities to both COBRE centers. The SCBC will offer expert design of molecular probes and synthesis of both small molecules and peptides, with an emphasis on the generation of fluorescent and other tagged molecules. SCBC will also offer bioassays of molecular probes, including whole cell assays and assays using zebrafish, to bridge a gap that currently exists between very high resolution imaging of cells in culture and low resolution imaging of fluorescent tracers in rodents. The newly established SCBC would function synergistically with other CMADP-funded Core facilities, including the Genome Sequencing Core, to identify genes that impact functions of probes in vivo, and the Microfabrication and Microfluidics Core, to develop devices for imaging and chemical analysis. This integration is designed to empower faculty to use chemical biology approaches to investigate biological problems. The SCBC provides investigators with access to highly qualified personnel with experience in synthetic organic chemistry, biochemistry, microscopy, and approaches for optimization of biological properties of synthetic molecules. The Center has two Co-Core Leaders from the Department of Medicinal Chemistry at KU. Prof. Blake Peterson will continue to be the Leader of the CMADP’s part of the SCBC. Prof. Tom Prisinzano is the Leader of the CBID part of the SCBC. The Director of SCBC is Dr. Chamani Perera. The specific aims that will be addressed by the SCBC for this Phase II proposal are: (1) to continue to integrate resources from the proposed COBRE Center for Molecular Analysis of Disease Pathways Phase II with the existing COBRE Center for Chemical Biology of Infectious Disease Phase I to further establish the new SCBC, gain economies of scale, and serve faculty affiliated with the COBRE CMADP; (2) design and synthesize molecular probes of biological systems for faculty investigators; (3) enable faculty clients to conduct bioassays in cell culture and zebrafish models; and (4) provide outreach and administrative support necessary to manage Core activities, and offer services to the larger biomedical research community in the state of Kansas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synthetic Lethal Targeting of Growth Factor Receptors
  • 批准号:
    9218305
  • 项目类别:
  • 资助金额:
    $32.91万
  • 财政年份:
    2017
  • 负责人:
    BLAKE PETERSON
  • 依托单位:
Synthetic Lethal Targeting of Growth Factor Receptors
  • 批准号:
    10065292
  • 项目类别:
  • 资助金额:
    $35.69万
  • 财政年份:
    2017
  • 负责人:
    BLAKE PETERSON
  • 依托单位:
Tissue-specific delivery of probes by control of membrane trafficking of endoprot
  • 批准号:
    7817256
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    BLAKE PETERSON
  • 依托单位:
Tissue-specific delivery of probes by control of membrane trafficking of endoprot
  • 批准号:
    7937894
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    BLAKE PETERSON
  • 依托单位:
海外基金